Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype

被引:24
|
作者
Geerdink, Jasper X. [1 ,2 ]
Simons, Sami O. [1 ]
Pike, Rebecca [3 ]
Stauss, Hans J. [3 ]
Heijdra, Yvonne F. [1 ]
Hurst, John R. [2 ]
机构
[1] Radboud Univ Nijmegen, Dept Resp Med, Med Ctr, Nijmegen, Netherlands
[2] UCL, UCL Resp, London, England
[3] UCL, Inst Immun & Transplantat, London, England
来源
RESPIRATORY RESEARCH | 2016年 / 17卷
关键词
COPD; COPD exacerbation; Respiratory immunology; Flow cytometry; Adaptive immunity; OBSTRUCTIVE PULMONARY-DISEASE; EPSTEIN-BARR-VIRUS; T-CELL RESPONSES; INFECTION; PERSISTENCE; MEMORY; HETEROGENEITY; DYSFUNCTION; SEVERITY; SYMPTOMS;
D O I
10.1186/s12931-016-0456-y
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Some COPD patients are more susceptible to exacerbations than others. Mechanisms underlying these differences in susceptibility are not well understood. We hypothesized that altered cell mediated immune responses may underlie a propensity to suffer from frequent exacerbations in COPD. Methods: Peripheral blood mononuclear cells (PBMCs) were obtained from 24 stable COPD patients, eight frequent exacerbators (>= 3 diary-card exacerbations/year) and 16 infrequent exacerbators (< 3 diary-card exacerbations/year). Detailed multi-parameter flow cytometry was used to study differences in innate and adaptive systemic immune function between frequent and infrequently exacerbating COPD patients. Results: The 24 COPD patients had a mean (SD) age of 76.3 (9.4) years and FEV1 1.43 (0.60) L, 53.3 (18.3)% predicted. PBMCs of frequent exacerbators (FE) contained lower frequencies of CD4+ T central memory cells (CD4+ Tcm) compared to infrequent exacerbators (IE) (FE = 18.7 %; IE = 23.9 %; p = 0.035). This observation was also apparent in absolute numbers of CD4+ Tcm cells (FE = 0.17 x 10(Lambda)6/mL; IE = 0.25 x 10(Lambda)6/mL; p = 0.035). PBMCs of FE contained a lower frequency of CD8+ T effector memory cells expressing HLA-DR (Human Leukocyte Antigen - D Related) compared to IE COPD patients (FE = 22.7 %; IE = 31.5 %; p = 0.007). Conclusion: Differences in the adaptive systemic immune system might associate with exacerbation susceptibility in the `frequent exacerbator' COPD phenotype. These differences include fewer CD4+ T central memory cells and CD8+ T effector memory cells.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype
    Jasper X. Geerdink
    Sami O. Simons
    Rebecca Pike
    Hans J. Stauss
    Yvonne F. Heijdra
    John R. Hurst
    Respiratory Research, 17
  • [2] Efficacy of Roflumilast in the COPD Frequent Exacerbator Phenotype
    Wedzicha, Jadwiga A.
    Rabe, Klaus F.
    Martinez, Fernando J.
    Bredenbroeker, Dirk
    Brose, Manja
    Goehring, Udo-Michael
    Calverley, Peter M. A.
    CHEST, 2013, 143 (05) : 1302 - 1311
  • [3] COPD: Proteomic Profile of the Frequent Exacerbator Phenotype
    Gea, J. G.
    Pascual-Guardia, S.
    Casadevall, C.
    Castro-Acosta, A.
    Bellido-Calduch, S.
    Seijo, L.
    Peces-Barba, G.
    Lopez-Campos, J.
    Cosio, B. G.
    Faner, M.
    Agusti, A.
    Monso, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] DEFINING THE FREQUENT EXACERBATOR PHENOTYPE DURING A PANDEMIC IN COPD
    Dayal, Parul
    Dimond, Colin
    Yang, Xiaoying
    Kent, Matthew
    Rizzo, Shemra
    Mohan, Divya
    CHEST, 2021, 160 (04) : 1786A - 1787A
  • [5] Time to Understand the Infrequency of the Frequent Exacerbator Phenotype in COPD
    Labaki, Wassim W.
    Martinez, Fernando J.
    CHEST, 2018, 153 (05) : 1087 - 1088
  • [6] Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype
    Del Rio, Adolfo Domenech
    Montiel, Ana Munoz
    Castano, Patricia Gutierrez
    Casares, Natalia Garcia
    Chaparro, Miguel Angel Sanchez
    Rios, Jose Luis De La Cruz
    Felices, Pedro Valdivieso
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [7] Can we consider the "frequent exacerbator" a reliable COPD phenotype?
    Bigazzi, Francesca
    Garcea, Alessio
    Torricelli, Elena
    Bonti, Viola
    Paoletti, Matteo
    Camiciottoli, Gianna
    Pistolesi, Massimo
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [8] PHENOTYPE OF COPD: "FREQUENT EXACERBATOR" AND BIOMARKERS USE IN CLINICAL PRACTICE
    Davidescu, Lavinia
    Davidescu, Darius Andrei
    Voita-Mekeres, Floricavoi
    Goman, Anca
    Motoc, Nicoleta Stefania
    Rajnoveanu, Ruxandra
    Man, Milena Adina
    PHARMACOPHORE, 2023, 14 (04): : 40 - 49
  • [9] Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients
    Wu, Yao-Kuang
    Su, Wen-Lin
    Yang, Mei-Chen
    Chen, Sin-Yi
    Wu, Chih-Wei
    Lan, Chou-Chin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 2475 - 2485
  • [10] Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype
    Zhao, Dongxing
    Abbasi, Asghar
    Rossiter, Harry B.
    Su, Xiaofen
    Liu, Heng
    Pi, Yuhong
    Sang, Li
    Zhong, Weiyong
    Yang, Qifeng
    Guo, Xiongtian
    Zhou, Yanyan
    Li, Tianyang
    Casaburi, Richard
    Zhang, Nuofu
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2379 - 2388